Product overview

Name Mibefradil dihydrochloride
Alternative names Ro 40-5967
Purity >95%
Description Potent, reversible T- / L-type Ca2+ channel blocker
Write Your Own Review
You're reviewing:Mibefradil dihydrochloride
Rate this item:

Images

Mibefradil dihydrochloride product vial image | Hello Bio

Biological Data

Biological description Potent and reversible T-type (IC50 = 865 nM) and L-type (Ki = 8.2 nM) Ca2+ channel blocker. Exhibits 10-15-fold selectivity for T-type channels over L-type channels. Cell permeable. Displays antihypertensive and hypoglycemic properties.

Solubility & Handling

Storage instructions -20°C
Solubility overview Soluble in water (50mM) or DMSO (100mM)
Important This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use

Calculators

Molarity

=
x
x
More Info

Dilution

x
=
x
More Info

Chemical Data

Purity >95%
Chemical name (1S,2S)-2-[2-[[3-(1H-Benzimidazol-2-yl)propyl]methylamino]ethyl]-6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenyl methoxyacetoacetate dihydrochloride
Molecular Weight 568.56
Chemical structure Mibefradil dihydrochloride  [116666-63-8] Chemical Structure
Molecular Formula C29H38FN3O3.2HCl
CAS Number 116666-63-8
PubChem identifier 60662
SMILES Cl.Cl.COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=C(N2)C=CC=C3)CCC2=C(C=CC(F)=C2)[C@@H]1C(C)C
InChi InChI=1S/C29H38FN3O3.2ClH/c1-20(2)28-23-12-11-22(30)18-21(23)13-14-29(28,36-27(34)19-35-4)15-17-33(3)16-7-10-26-31-24-8-5-6-9-25(24)32-26;;/h5-6,8-9,11-12,18,20,28H,7,10,13-17,19H2,1-4H3,(H,31,32);2*1H/t28-,29-;;/m0../s1
InChiKey MTJLQTFHJIHXIX-GDUXWEAWSA-N
MDL number MFCD00868314

References for Mibefradil dihydrochloride

References are publications that support the biological activity of the product
  • Mibefradil reduces blood glucose concentration in db/db mice.

    Lu Y et al (2014) Clinics (Sao Paulo) 69(1) : 61-7.
  • The T- and L-type calcium channel blocker (CCB) mibefradil attenuates leg edema induced by the L-type CCB nifedipine in the spontaneously hypertensive rat: a novel differentiating assay.

    Major TC et al (2008) J Pharmacol Exp Ther 325(3) : 723-31.
  • A mibefradil metabolite is a potent intracellular blocker of L-type Ca(2+) currents in pancreatic beta-cells.

    Wu S et al (2000) J Pharmacol Exp Ther 292(3) : 939-43.

3 Item(s)